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Abstract
Background: Accurate and rapid identification of microorganisms causing periprosthetic joint infections (PJIs) are
necessary for choosing an appropriate antibiotic therapy. Therefore, molecular techniques are suggested for
diagnosis in suspected PJIs. The Broad-range PCR and High-Resolution Melt Analysis (HRMA) were evaluated for the
identification of causative organisms of PJIs in this study.
Results: For 47 of 63 specimens, both the culture and broad-range PCR were positive. The culture was found to be
able of organism’s detection in 74.6% (47/63) of patients. Of 47 positive cultures, 11 (23.4%) were polymicrobial and
36 (76.59%) were monomicrobial cultures, in which 34 (91.89%) cases were detected by HRM assay. The sensitivity,
specificity of HRMA vs monomicrobial culture were 91.89, 93.75%, respectively. The sensitivity, specificity of total
HRMA (mono + poly) vs culture were 82.92, 93.75%.
Conclusions: HRM assay coupled with broad-range PCR are effective screening, rapid, and relatively cost-effective
methods for discrimination of PJIs especially in aiding culture method. Using computer programs such as the
Matlab-2018b program for HRM data analysis is also valuable and helpful in diagnosis.
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Background
Periprosthetic joint infections (PJIs), are among import-
ant threats to global public health and are considered as
a main challenge after elective surgical procedures [1, 2].
Arthroplasty is a frequent surgical procedure for joint
replacement in end-stage arthritis [3, 4]. One of the
most serious and devastating complications after joint
arthroplasty is PJI [5, 6]. Also, higher revision arthro-
plasty rates could be due to PJI [7].
Prevalence of PJI is steadily increasing, mostly due to
more frequent usage of prosthetic joints [1, 2]. Given the
projected increase of joint replacement over the coming
decades turned into a challenging issue, such as diagno-
sis challenges, high morbidity, the economic burden for
patients and healthcare costs [5, 8, 9]. In managing PJI,
one of the most important aspects is a prompt and de-
finitive diagnosis of the causative organisms for the se-
lection of appropriate treatment options and avoiding
unnecessary multiple surgical procedures. In up to 50%
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of PJI cases, the infecting organism is not isolated in cul-
tures and the risk of reinfection in negative culture cases
is 4.5 times higher than in positive culture cases [10–12].
Since most of the methods for the detection of causa-
tive bacteria are time-consuming and costly, several fast
and accurate molecular techniques have been investi-
gated to improve the sensitivity of PJI diagnosis [13].
Therefore, molecular techniques such as broad-range
PCR targeting the 16SrRNA gene (broad-range PCR)
and high-resolution melt curve analysis (HRMA) of 16 s
hypervariable gene regions contribute to PJIs rapid diag-
nosis. The Full-length 16S rRNA gene presents in all
bacteria and is including nine hypervariable regions (V1-
V9). Broad-range PCR identify non-viable bacterial DNA
in specimens whose culture are negative because of con-
suming antibiotics [14, 15].
The HRMA is as post-PCR technique with amplified
on PCR amplicons and there is a relation between
temperature and extent of double-stranded DNA de-
naturation. In this technique, %G-C content, amplicons
length (<300 bp) and the nucleotide sequence contribute
to melting temperature (Tm) and fluorescent dye bind-
ing to double-stranded DNA in the PCR reaction. In this
method, as the temperature increases, the double-
stranded DNA detaches into single-strands and leading
to a reduction in fluorescence intensity. The advantages
of this approach can be mentioned to rapid-speed, rela-
tively cost-effective, use of generic instrumentation ac-
cessible in many laboratories, simplicity, single step, and
an alternative to gel-based techniques [16–19].
An 18-month study was performed on patients with
knee and hip PJIs from tertiary care hospitals. In this re-
search, the infecting organisms were identified using
cultures and phenotypic methods, broad-range PCR,
HRMA in synovial fluid and tissue specimens from pa-
tients with suspected knee and hip PJIs. The raw data of
HRMA were translated and analyzed by the Matlab-
2018b program. To our knowledge, there have been no
studies evaluating 16S rRNA gene variable regions
HRMA to identify the causative organisms in PJIs.
Results
Over the study period, 63 patients (42 women and 21
men) with suspected knee or hip PJIs, and criteria in-
cluded, were analyzed. Of 63 patients undergoing total
arthroplasty, 33 knee and 30 hip were involved.
The specimens consisted of 39 synovial fluids and 24
tissues. Among the total 63 patients who were investi-
gated, 47 (74.6%) had positive culture, while in 16
(25.38%) the cultures were negative. Of 47 positive
cultures, the most common causative pathogen was
Staphylococcus aureus (S. aureus, 17 cases, 36.17%)
followed by coagulase-negative staphylococci (CoNS, 14
cases, 29.78%). Methicillin-resistant S. aureus (MRSA)
was isolated in 5 cases (10.63%) and methicillin-resistant
coagulase-negative staphylococci (MR-CoNS) were iso-
lated in seven cases (14.89%). No strains were found
vancomycin-resistance among Methicillin-resistant
Staphylococcus spp. (MRS spp) isolates by E-test.
Of 47 positive cultures, 36 (76.59%) infections were
monomicrobial and 11 (23.4%) were polymicrobial. In
monomicrobial PJIs, the most common isolated
bacterium was S. aureus (12/47, 25.53%) and several
Gram-negative bacterial strains were isolated from
specimens, such as Escherichia coli, Klebsiella pneu-
monia, Pseudomonas aeruginosa. Also, two isolates of
Brucella melitensis were detected from monomicrobial
PJIs. Enterococcus faecalis (11/47, 23.4%) isolates were
the most commonly identified species in polymicro-
bial PJIs which one isolate was vancomycin-resistant
enterococci (VRE). Escherichia coli (6/47, 12.76%) iso-
lates were the most frequent isolate of Gram-negative
in polymicrobial PJIs. Anaerobic pathogens as Finegol-
dia magna (F. magna) and Cutibacterium avidum (C.
avidum) were isolated in three cases (5.45%) in mono
and polymicrobial PJIs which are shown in Fig. 1.
Broad-range PCR was performed on 63 specimens of
which 47 specimens were positive. Overall, the results
of culture and broad-range PCR were not in agree-
ment with the two cases. There was one case of posi-
tive broad-range PCR in which the culture was
negative and F. magna was detected with sequencing
method. Furthermore, there was one case of culture-
positive and S. aureus was identified in which broad-
range PCR did not detect the organism.
At first, a reference library based on Tm and melting
curves of 19 reference strains was established by HRMA
for detection of pathogens. Derivative and Aligned Melt
Curves of three strains (Klebsiella pneumonia ATCC
700603, S. aureus ATCC 25923 and Brucella melitensis)
with three 16SrRNA regions are outlined in Fig. 2. The
generated melt curves of samples (48 synovial fluid and
tissue specimens) were compared with melt curve
database of reference strains to perform bacterial identi-
fication that are shown in Fig. 3. The causative organ-
isms were identified by HRMA in all 47 cases which
broad-range PCR were positive (36 monomicrobial and
11 polymicrobial infections). Among 37 detected mono-
microbial infections by HRMA, 34 (91.89%) cases were
concordant with culture in which the four cases were
accordant at the genus level and three (8.1%) cases were
discordant with culture. The sensitivity, specificity, ac-
curacy, Positive predictive values (PPV) and Negative
predictive (NPV) of HRMA vs culture for detecting the
monomicrobial infections in PJI samples were 91.89,
93.75, 97.14, 83.33, and 92.45%, respectively.
From 11 remaining case with a polymicrobial positive
culture, HRMA was able to detect 7 cases (63.63%) at
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least with one of the causative bacterial species (one case
was identified at the genus level) that were concordance
to culture findings (Table 1). The Overall sensitivity,
specificity, PPV and NPV, and accuracy of total HRMA
(mono + poly) vs culture were 82.92, 93.75, 97.14, 68.18,
and 85.96%, respectively.
All three gene regions of the reference strains of S.
aureus and S. epidermidis outlined in Fig. 4, indicating
that the two strains are distinct.
Finally, for confirmation of culture and HRMA de-
tected strains, the sequencing method was performed.
GenBank accession numbers for the 16S rRNA
sequencing of clinical isolates determined in the present
study are; Finegoldia magna MH201143.1, Finegoldia
magna MK516859.1, Staphylococcus epidermidis
MK516263.1, Enterococcus faecalis MK516261.1, Coryne-
bacterium simulans MK516260.1, Cutibacterium avidum
MH201146.1.
Discussion
There are significant challenges in management of PJIs.
For effective management, accurate microbiologic
Fig. 1 Distribution of detected microorganisms from PJIs MRSA: Methicillin-resistant Staphylococcus aureus, MSSA: Methicillin-susceptible
Staphylococcus aureus, MRSE: Methicillin-resistant Staphylococcus epidermidis, MSSE: Methicillin-susceptible Staphylococcus epidermidis, MR-S.
haemolyticus: Methicillin-resistant Staphylococcus haemolyticus, Other MR-CoNS: Other Methicillin-Resistant Coagulase-Negative Staphylococci,
Other MS-CoNS: Other Methicillin-susceptible Coagulase-Negative Staphylococci, VSE: Vancomycin-sensitive Enterococcus faecalis, VRE:
Vancomycin-resistant Enterococcus faecalis, C.simulans: Corynebacterium simulans, D.incerta: Desemzia incerta, N.dassonville: Nocardiopsis dassonville,
C.avidum: Cutibacterium avidum, F.magna: Finegoldia magna, B.melitensis: Brucella melitensis, E.coli: Escherichia coli, P.mirabilis: Proteus mirabilis,
E.tarda: Edwardsiella tarda, P.aeruginosa: Pseudomonas aeruginosa, P.stutzeri: Pseudomonas stutzeri, P.oryzihabitans: Pseudomonas oryzihabitans,
L.adecarboxylata: Leclercia adecarboxylata
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diagnosis of infecting organisms is important. False-
negative culture and longtime for diagnosis are critical
challenges for conventional methods. Molecular
methods had been suggested solving these problems but
their usage in routine diagnostics is still controversial.
In the present study, the prevalence of infection-
causing microorganisms was determined and the role of
molecular methods such as broad-range PCR and
HRMA in assisting the culture method for the identifica-
tion of microorganisms was investigated.
Fig. 2 A: HRMA Derivative Melting Curves and B: HRMA Aligned Melting Curves for some of Reference strains 1a: V1 region of K. pneumonia
ATCC 700603, 1b: V3 region of K. pneumonia ATCC 700603, 1c: V6 region of K. pneumonia ATCC 700603, 2a: V1 region of S. aureus ATCC 25923,
2b: V3 region of S. aureus ATCC 25923, 2c: V6 region of S. aureus ATCC 25923, 3a: V1 region of B. melitensis 16 M ATCC 23456, 3b: V3 region of B.
melitensis 16 M ATCC 23456, 3c: V6 region of B. melitensis 16 M ATCC 23456
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The main advantages of HRMA are the implementa-
tion of a relatively cost-effective, single-step and rapid
technique for directly extracted clinical specimens and
compared to other molecular methods.
The culture method was found to be able of detection
of microorganisms in 74.6% (47/63) of patients as
determined by the Philadelphia Consensus Criteria
(PCC) and clinician’s diagnosis. This improvement can
easily be explained by optimal conditions such as accur-
ate sampling, use of various and appropriate culture
media in different atmospheric conditions and prolonged
incubation time. It is important to note that the culture
Fig. 3 a: HRMA Derivative Melting Curves and b: HRMA Aligned Melting Curves for V1, V3, V6 regions of S. aureus ATCC 25923 and S. aureus
isolated from clinical (PJI) specimens Ref-V1: Reference strain-V1 region, S-V1: Clinical specimen-V1 region, Ref-V3: Reference strain-V3 region, S-V3:
Clinical specimen-V3 region, Ref-V6: Reference strain-V6 region, S-V6: Clinical specimen- V6 region
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P1 M / - S. aureus + S. aureus (81.60/0.7) S. aureus (84.10/0.1) S. aureus (83.70/0.5)
P2 M / - S. aureus + S. aureus (84.20/0.3) S. aureus (85.10/0.1) S.aureus (83.40/0.2)
P3 M / - S. aureus + S. aureus (84.30/0.4) S. aureus (85.10/0.1) S. aureus (83.00/0.2)
P4 M / - S. aureus + S. aureus (80.90/0.0) S. aureus (84.00/0.0) S. aureus (83.20/0.0)
P5 M / - S. aureus – S. aureus (84.70/0.8) S. aureus (84.40/0.6) S. aureus (83.70/0.5)
P6 M / - S. aureus + S. aureus (83.20/0.2) S. aureus (84.90/0.1) S. aureus (81.70/0.2)
P7 M / - S. epidermidis + S. epidermidis (83.50/0.2) S. epidermidis (85.10/0.4) S. epidermidis (83.70/0.1)
P8 M / - S. epidermidis + S. epidermidis (82.70/0. 2) S.epidermidis (85.80/0.2) S.epidermidis (83.80/0.2)
P9 M / - E. faecalis + S. epidermidis (83.10/0.6) S. epidermidis (85.60/0.0) S. epidermidis (83.20/0.4)
P10 M / - E. faecalis + E. faecalis (86.30/0.1) E. faecalis (85.80/0.3) E. faecalis (84.10/0.0)
P11 M / - S. haemolyticus + S. haemolyticus (83.80/0.1) S. haemolyticus (87.50/0.0) S. haemolyticus (83.80/0.5)
P12 M / - K. pneumoniae + K. pneumoniae (86.13/0.03) K. pneumoniae (86.80/0.7) K. pneumoniae (82.95/0.5)
P13 M / - E. coli + E. coli (85.40/0.4) E. coli (86.20/0.1) E. coli (84.50/0.3)
P14 M / - P. aeruginosa + P. aeruginosa (87.50/0.5) P. aeruginosa (85.30/0.8) P. aeruginosa (84.90/0.1)
P15 M / - B. melitensis + B. melitensis (82.60/0.0) B. melitensis (85.40/0.1) B. melitensis (86.40/0.4)
P16 M / - B. melitensis + B. melitensis (82.70/0.1) B. melitensis (85.40/0.1) B. melitensis (86.40/0.4)
P17 - / - – + F. magna (84.30/0. 0) F. magna (85.50/0.0) F. magna (82.20/0.0)
P18 M / - S. aureus + S. epidermidis (83.20/0.5) S. epidermidis (85.20/0.3) S. epidermidis (83.50/0.3)
P19 M / - S. aureus + S. epidermidis (83.10/0.6) S. epidermidis (85.20/0.3) S. epidermidis (83.80/0.0)
P20 M / - S. aureus + S. haemolyticus (83.70/0.2) S. haemolyticus (85.90/0.0) S. haemolyticus (83.40/0.3)
P21 M / - S. epidermidis + S. epidermidis (83.90/0.2) S. epidermidis (85.70/0.2) S. epidermidis (83.90/0.1)
P22 M / - S. aureus + S. aureus (83.40/0.3) S. aureus (85.50/0.0) S. aureus (83.20/0.5)
P23 M / - S. aureus + S. aureus (80.94/0.54) S. aureus (85.80/0.54) S. aureus (82.56/0.54)
P24 M / - S. aureus + S. aureus (80.94/0.04) S. aureus (84.10/0.1) S. aureus (82.80/0.4)
P25 M / - S. epidermidis + S. epidermidis (82.30/0.6) S. epidermidis (84.30/1.0) S. epidermidis (84.10/0.4)
P26 M / - S. epidermidis + E. faecalis (86.10/0.3) E. faecalis (84.20/0.7) E. faecalis (82.80/0.18)
P27 M / - S. epidermidis + S. epidermidis (83.20/0.6) S. epidermidis (84.20/0.22) S. epidermidis (83.60/0.81)
P28 M / - S. aureus + S. aureus (82.10/1.2) S. aureus (83.80/0.2) S. aureus (83.20/0.0)
P29 M / - S. epidermidis + E. faecalis (86.30/0.1) E. faecalis (85.80/0.3) E. faecalis (84.00/0.1)
P30 M / - S. epidermidis + S. epidermidis (80.90/0.8) S. epidermidis (85.50/0.2) S. epidermidis (84.20/0.5)
P31 M / - S. aureus + S. aureus (84.20/0.3) S. aureus (85.50/0.5) S. aureus (83.20/0.0)
P32 M / - S. aureus + S. epidermidis (81.70/0.0) S. epidermidis (84.10/1.2) S. epidermidis (83.80/0.1)
P33 M / - S. aureus + S. aureus (83.50/0.4) S. aureus (80.90/0.04) S. aureus (82.40/0.1)
P34 M / - E. faecalis + E. faecalis (85.89/0.51) E. faecalis (85.47/0.53) E. faecalis (83.73/0.07)
P35 M / - S. epidermidis + S. epidermidis (82.60/0.1) S. epidermidis (86.10/0.5) S. epidermidis (83.00/0.6)
P36 M / - S .aureus + S. aureus (81.50/0.2) S. aureus (86.10/0.3) S. aureus (83.10/0.5)
P37 M / - E. faecalis + E. faecalis (86.51/0.1) E. faecalis (81.98/4.02) E. faecalis (83.96/0.2)
P1 - / P S. epidermidis,
A. baumannii
+ F. magna (85.50/1.0) F. magna (85.20/0.3) F. magna (82.90/0.2)
P2 P / - S. aureus, P. mirabilis + S. sanguinis (83.60/0.1) S. sanguinis (86.30/0.1) S. sanguinis (83.90/0.1)
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results were positive for a significant percentage of pa-
tients who had taken antibiotics before sampling (23.4%,
11/47cases). Positive culture results may be owing to the
use of optimal conditions. Of the 16 suspected culture-
negative PJIs who met the consensus criteria, three cases
(18.75%) receiving empirical antibiotic therapy before
sampling, as expected, taking antibiotics has resulted in
negative cultures.
Yoon et al. in a review study reported that the preva-
lence of culture-negative PJIs are up to 42% [10].













P3 P / - S. aureus, C. avidum + C. avidum (85.80/0.1) C. avidum (89.00/0.1) C. avidum (85.60/0.3)
P4 P / - S. aureus, E. faecalis + S. aureus (83.90/0.2) S. aureus (85.90/0.4) S. aureus (83.10/0.4)
P5 P / - F. magna, E. faecalis + F. magna (84.20/0.3) F. magna (85.30/0.2) F. magna (82.70/0.0)
P6 P / - E .faecalis, P. mirabilis + F. magna (84.20/0.3) F. magna (86.80/1.3) F. magna (82.60/0.1)
P7 P / - S. epidermidis, yeast + S. aureus (80.90/0.0) S. aureus (84.80/0.8) S. aureus (83.60/0.4)
P8 P / - E. faecalis, P. mirabilis + S. aureus (80.90/0.0) S. aureus (83.30/0.7) S. aureus (82.10/1.1)
P9 P / - S. aureus, P. mirabilis + P. mirabilis (83.50/0.3) P. mirabilis (87.00/0.2) P. mirabilis (84.30/0.1)
P10 P / - E. coli, E. tarda + E. coli (84.30/0.0) E. coli (87.30/0.2) E. coli (84.50/0.1)
P11 P / - E. coli, A. baumannii,
E. faecalis
+ P. mirabilis (83.80/0.04) P. mirabilis (86.80/0.0) P. mirabilis (83.80/0.7)
aMultiple melting curve profiles were produced, indicating a polymicrobial infection
bHRMA, the most similar overall to reference strains
S. aureus: Staphylococcus aureus, S. epidermidis: Staphylococcus epidermidis, S. haemolyticus: Staphylococcus hemolyticus, E. faecalis: Enterococcus faecalis, S. sanguinis:
Streptococcus sanguinis, C. avidum: Cutibacterium avidum, F. magna: Finegoldia magna, B. melitensis: Brucella melitensis, E. coli: Escherichia coli, P. mirabilis: Proteus
mirabilis, E. tarda: Edwardsiella tarda, P. aeruginosa: Pseudomonas aeruginosa, A. baumannii: Acinetobacter baumannii
Fig. 4 HRMA Derivative Melting Curves of Reference strains for V1, V3, V6 regions of S. aureus ATCC 25923 and S. epidermidis strain Bjg (MK
516263) 1a: V1 region of S. aureus, 1b: V1 region of S. epidermidis, 2a: V6 region of S. aureus, 2b: V6 region of S. epidermidis, 3a: V3 region of S.
aureus, 3b: V3 region of S. epidermidis
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Moshirabadi et al. from Iran reported that the incidence
of negative culture in PJIs are as high as 68% [20]. Kim
et al. reported that the incidence of negative culture out-
come was 42% in knee PJIs which was significantly
higher compared to other published studies [21]. In the
study of Bejon et al., frequent of culture-negative infec-
tion was 41%, and of these, 93% taking a minimum of
14 days’ antibiotic-free gap before sampling [22].
Our data show improving the culture method can be
effective in increasing the positive cultures among anti-
biotic users, to some extent. Overall, our results revealed
that the most common bacteria isolated from PJIs were
Gram-positive cocci, with S. aureus (36.17%) and CoNS
(29.78%) being the most prevalent. In most of the stud-
ies, Gram-positive cocci are involved in the majority of
hip and knee PJIs. This is driven largely by infection with
S. aureus and CoNS [23, 24]. MRS spp., especially S.
aureus and S. epidermidis, will impose unnecessary anti-
biotic selection pressures and also, additional costs on
treating patients [22]. In our evidence, the percentage of
MRS isolates was 25.53% in which 10.63% S. aureus and
14.89% CoNS were methicillin resistance. It comprised
about one-third of all cases (17/47). There is no report
on the prevalence of MRS PJIs in our country and it
seems that it was consistent with the prevalence of MRS
in some studies [25, 26]. A study by Uckay et al. revealed
45 (75%) of the orthopedic infections caused by CoNS
were MR-CoNS strains [27]. Among 47 PJIs during our
study period, 11 (23.4%) cases were due to Enterococcus
spp. and of these, two (4.25%) cases were related to VRE.
Berbar et al. reported Enterococcus spp. accounts for
only 3% of PJI [28]. In Ortega et al. study was showed
that none of the Enterococcus spp. were resistant to
vancomycin [29]. Our evidence revealed monomicrobial
PJIs were more frequent than polymicrobial PJIs and
accounted for 76.59% (36 of 47 cases) and 23.4% (11 of
47 cases, respectively. However, the prevalence of poly-
microbial infection is high in our findings compared to
most other studies [30, 31]. Hence, a high incidence of
polymicrobial infections should be noticed in treatment
of PJIs. Tan et al. reported 10.3% (108 of 1045) of the
PJIs treated at their institution were polymicrobial [30].
In this study Enterococcus species, S. aureus, and aer-
obic Gram-negative bacilli, including E. coli, are the
most frequently isolated bacteria in polymicrobial PJIs,
also the frequency of other Gram- negative organisms
was higher in polymicrobial PJIs than in monomicrobial
PJIs. It should be mentioned that patients with a polymi-
crobial PJI had higher treatment failure which may be
related to Gram-negative PJIs [31]. The anaerobic bac-
teria are identified rarely and are one of the significant
causative agents of PJIs. In the present study, 6.38% (3/
47) of PJIs were an anaerobic infection caused by two
isolates of F. magna and one C. avidum. Khosravi et al.
reported the prevalence of anaerobes in PJIs was 1.9%
[32]. Soderquist et al. identified F. magna isolates from
nine patients from 2004 to 2016 [33]. Zeller et al. re-
vealed among 1179 PJIs treated during the study period,
15 (1%) PJIs were due to C.avidum which were isolated
from patients with hip arthroplasty [34].
Broad-range PCR is useful for rapid reports of un-
known bacterial pathogens presence in patient’s clinical
specimens especially for whom are infection-suspicion
and culture-negative.
The broad-range PCR specifies only bacterial DNA
presence in specimens which is a disadvantage of PCR
and this problem can resolve with HRMA. This study
showed that broad-range PCR was able to detect bacter-
ial DNA in 97.87% (46/47) of culture-positive samples.
Also in one negative culture case, broad-range PCR was
positive, therefore the results of culture and broad-range
PCR were not in agreement with each other only in two
cases. This finding is consistent with Rampini et al. re-
sults that showed a high concordance of 90% for broad-
range PCR and culture [35]. Fifty percent concordance
for cultivation and broad-range PCR was observed in
Akram et al. study [3]. The results of PCR and HRMA
was positive only for one negative culture case, in which
F. magna was detected which confirmed by 16 s rRNA
gene sequencing [36].
At our experiment, 16srRNA gene HRMA was found to
be able of organism identification in 91.89% (34/37) of pa-
tients which were concordant with monomicrobial culture
results (four cases were accordant at the genus level) and
8.1% (3/37) of HRMA results were discordant with
culture. It is likely that these infections were polymicro-
bial, with only one of the pathogens was identified by
culture and, the other causative agent distinguished by
HRMA, due to HRMA’s inability to resolve polymicrobial
infections. In confirmation of this, in 3/37 discordant
samples, HRMA generated multiple melting peaks in their
derivative plots. Our finding is consistent with Won et al.
study that evaluated a broad-based PCR assay coupled
with HRMA for bacterial identification in bacterial septic
patients (52 cases). Their assay results were concordant
with culture findings in 46/52 (88.5%) [37].
In our study, of 47 (mono + poly) cases, 41 (87.23%)
cases were detected by HRMA. The sensitivity and
specificity of total HRMA (mono + poly) vs culture were
82.92, 93.75%., respectively. Hardick et al. showed that
HRMA concordance with species identification of
bacterial pathogens in ascitic fluids from patients with
suspected spontaneous bacterial peritonitis (mono+poly)
was 70.6% and the following sensitivity and specificity
for 16S PCR-HRMA compared with culture techniques
were 100 and 91.5%, respectively [38].
The main reason for the decrease in the sensitivity of
total HRMA in our study is the inability of HRMA
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method in the detection of bacteria associated with poly-
microbial infections.
In the present study, multiple hypervariable regions
melt curve profiles of clinical strains were compared
with reference strains using the Matlab-2018b program.
Nevertheless, in polymicrobial infections, HRMA gener-
ated multiple dominant peaks in the derived melting
curves. The Matlab-2018b program evidently supported
HRMA to correctly identified individual bacterial species
from polymicrobial samples (7/11) in this study. There-
fore, presence multiple melting peaks in their derivative
plots can suggest the presence of multiple pathogens
that aiding in antibiotic selection for suspected polymi-
crobial infections. Won et al. had problems with polymi-
crobial infections and HRMA generated multiple
melting peaks in their plots accordance with our study
[37]. It should be noted that the probability of sample
contamination should be considered when multiple
melting peaks are obtained. The appropriate programs
such as the Matlab-2018b program are effective for ana-
lyzing HRMA data similar to published studies by Atha-
manolap et al. [39]. Finally, although the identification of
bacteria by conventional methods are time-consuming,
the culture method is relatively practical for the identifi-
cation of bacteria and unlike most molecular methods,
antibiotic susceptibility can be determined by the culture
method. However, some factors such as false-negative
culture, slow-growing pathogens, the formation of bio-
film and antibiotic prophylaxis reduce the accuracy of
the culture method in identifying bacteria. It can be con-
cluded that molecular techniques such as broad-range
PCR and HRMA are complementary to this method for
organism identification. Some of the investigators used
different molecular techniques such as polymerase chain
reaction-restriction fragment length polymorphism
(PCR-RFLP) technique and new technology of Next-
Generation Sequencing (NGS) to detect PJI [12, 20].
Despite the advantages of these techniques for the
identification of causative organisms in PJI, significant
challenges are addressed below; the PCR-RFLP tech-
nique is a gel-based and time-consuming process and
large amounts of DNA required [40]. While NGS tech-
nique is costly, it does not require isolation of a pure
bacteria species [41].
According to the descriptions given about culture
method and HRMA, as well as their advantages and dis-
advantages, culture method as a Gold standard method
along with a molecular method such as HRMA, to accel-
erate the response in laboratory will be many helpful.
The main limitation of this study was related to PCR-
HRMA which is its inability to resolve polymicrobial
infections. In HRMA assay, polymicrobial PJIs can be
detected with respect to multiple dominant peaks in the
derivate melting curve, but the individual causative
agents responsible for polymicrobial PJIs cannot be cor-
rectly diagnosed by our assay [37, 38]. Nonetheless, in
the current study, three discrepant samples with mono-
microbial growth by culture were observed to have mul-
tiple organisms by PCR-HRMA. These results imply
either contamination or a potential benefit of PCR-
HRMA than conventional cultural methods to determine
the presence of polymicrobial identifications. Identifying
the pathogens at an earlier time point is a significant
clinical benefit and help to prompt treatment [38].
In order to resolve the problem of polymicrobial PJIs
identification, the use of universal digital PCR and high-
resolution melt along with developed Nanoarray is sug-
gested [42]. In HRM assay, if the causative agents of
infections are not present in reference strains library, it
is not detectable by the HRMA. Consequently, we
recommend a vast reference strains library. Other PCR-
HRMA limitations were exchanges in DNA base pairs.
Changes in Tm: approx. 0.8–1.4 °C and more were per-
formed by exchange between DNA G: C and T: A base
pairs, this range and lower than this temperature range
were considered as one type of bacteria [43]. Hence, in
our study, the Tm difference index of HRMA was con-
sidered 0–1.4 °C which more than this range were dis-
crepant samples with culture findings and reference
strains library. Owning to the limited range of a 96–well
microtiter plate, in the Real-time PCR instruments and
software, it is not able to process and comparing refer-
ence strains with clinical samples for three 16SrRNA
gene regions across all rounds, entirely. We optimized
the problem with the Matlab-2018b program [39].
Conclusion
The present evidence demonstrates HRM assay is an ef-
fective screening approach to identify the pathogens in-
volved in PJIs especially in aiding culture method. This
knowledge is revealed that the HRMA is a technique of
single step, rapid and relatively cost-effective. This ap-
proach can detect DNA in different clinical specimens
directly extracted from PJI samples. Data analysis using
Matlab-2018b program was valuable and practical to
compare between detected organisms and reference
strains. Using the HRMA approach and data analysis by
the Matlab-2018b, monomicrobial PJIs in agreement
with culture findings gained better results than polymi-
crobial PJIs. Future advances in this field should focus
on approaches for definitive diagnosis of the causative
organisms in polymicrobial PJIs identification.
Material and methods
Study design and population
In this study between August 2017 and November 2019,
63 patients (42 women and 21 men) aged 41–85 years
were qualified. The specimens (39 synovial fluids and 24
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tissues from knee and hip joint) were taken from pa-
tients who underwent knee and hip joint surgeries in
PJIs (63 cases) under observing tertiary care hospitals lo-
cated in Tehran, Iran. Patients characteristics were docu-
mented according to the involved joints (hip and knee),
age, gender, inflammatory markers (CRP, ESR), white
blood cell, fever, antibiotic consumption (in ≤ 2 to
4 weeks preceding surgery) [21].
Case definition
The cases included in this study belonged to the PJIs (63
cases). The patients who had one or two major criteria
for PJI based on PCC, the first, two positive cultures of
the same pathogens or the second, a sinus tract in asso-
ciation with the joint - and/or had two or three of the
following minor criteria - raised up serum CRP and ESR
(with abnormal values of > 10 mg/ml and > 30 mm/h, re-
spectively), raised up synovial leukocyte count or raised
up synovial neutrophil percentage (with abnormal values
and percentage of > 1700 cell/μl and > 65% respectively,
for knees and > 3000 cells/μl and > 80%, respectively, for
hips were considered abnormal) were considered as
cases of PJI [20, 21, 44–46].
Microbiological culture and biochemical testing
approaches
The synovial fluid and tissue specimens were taken dur-
ing aspiration and knee and hip joint surgery. Specimens
were cultured on both of the broth (such as thioglycolic
acid, brain heart infusion broth, and resin-containing
BACTEC Blood Culture Media) and agar medium (such
as brain heart infusion, blood, chocolate, MacConkey,
and schaedler agar supplemented with Vitamin K1) in
37 °C for at least 48 h under aerobic, microaerophilic (with
5–7% CO2) and anaerobic conditions. The incubation
period was extended to 14–21 days for slow-growing and
fastidious microorganisms. The identification of isolated
organisms was done by biochemical tests [47] and were
confirmed with VITEK 2 Compact system (BioMerieux,
USA). Vancomycin minimum inhibitory concentrations
were determined by the E-test method (MIC test strip, lio-
filchem, Italy) for MRS ssp. Additionally, VRE was deter-
mined using the disk diffusion test.
Extraction of nucleic acids
DNA extraction of 63 specimens (For each patient, one
synovial fluid specimen was included and tissue speci-
men was included for patients who had no synovial
fluid) was done by Qiagen kit (QIAamp DNA Mini Kit,
Germany). The quality and quantity of the extracted
DNA were assayed by spectrophotometry at 260 and
280 nm UV-vis light. Extracted DNA was stored at −
20 °C for the PCR and HRMA [20].
Broad-range PCR
The 16SrRNA PCR of 63 specimens was achieved by
universal primers (27F: AGAGTTTGATCCTGGC
TCAG, 1429R: GGTTACCTTGTTACGACTT) [35].
PCR reactions were performed in 25 μl final concentra-
tion: 10 μl of the master mix, 0.5 μl of 25 pmol F primer,
0.5 μl of 25 pmol R primer, 12 μl sterile distilled water
and 2 μl genomic DNA. PCR conditions were 95 °C for
300 s, followed by 37 cycles of 95 °C for 45 s, 58 °C for
30s (annealing temperature), 72 °C for 70s and final ex-
tension 72 °C for 300 s [14].
The HRMA of 16S rRNA gene hypervariable regions
The 16S rRNA HRMA (Applied Biosystems Step One-
Plus Systems, USA) was performed for samples with
positive broad-range PCR (48 synovial fluid and tissue
samples) and of these, one sample was with a positive
culture and negative broad-range PCR.
At first, HRMA was done with extracted DNA of 19
species of bacteria (reference strains) which are associ-
ated with PJIs. By targeting V1, V3, and V6 hypervariable
regions, each of species had a specific melting curve
group consist of three melting curves. Finally, a melting
curve library was prepared to depend on reference
strains. In the following, HRMA was done with extracted
DNA of synovial fluid and tissue samples and then melt-
ing curve data generated from each of the samples were
compared to the melting curve library of reference
strains [14, 21, 48]. Reference strains used in this study
were S. aureus ATCC 29213, S. aureus ATCC 25923, S.
epidermidis strain Bjg (MK 516263), S. hemolyticus
ATCC 29970, S. saprophyticus ATCC 15305, Micrococ-
cus luteus ATCC 15307, Enterococcus faecalis ATCC
29212, Streptococcus sanguinis ATCC 10566, Finegoldia
magna ATCC 1766, Cutibacterium ATCC 25573, Hae-
mophilus influenza ATCC 49766, Pseudomonas aeruginosa
27,853, Escherichia coli ATCC 25922, Klebsiella pneumonia
ATCC 700603, Proteus mirabilis ATC 43071, Acinetobacter
baumannii ATCC 19606, Brucella melitensis 16M ATCC
23456, Mycobacterium tuberculosis H37Rv, Corynebacter-
ium simulans strain BJd (MK 516260).
HRMA reactions were performed in a 20 μl final
volume and contained the following final concentrations:
4 μl of 5x EvaGreen master mix (5x HOT FIREPol Eva-
Green HRM Mix by Solis BioDyne), 0.6 μl of 10 pmol F
primer, 0.6 μl of 10 pmol R primer (Table 2), 13.8 μl ster-
ile deionized water and 1 μl genomic DNA (each of three
primer pairs were in three reactions, individually). PCR
and HRMA conditions were 95 °C for 300 s, followed by
40 cycles of 95 °C for 10s, 58 °C for 30s (annealing
temperature), and 72 °C for 10s and melt curve stage
with 95 °C for 15 s, 60 °C for 60s, 95 °C for 15 s. Some of
the HRMA-positive samples were confirmed by DNA
Bourbour et al. BMC Microbiology          (2021) 21:112 Page 10 of 13
sequencing and recorded in the nucleotide database in
NCBI.
Processing for HRMA results by Matlab-2018b program
To assay HRM, experimentally produced reference
strains and clinical isolates melting curves (raw melting
data files) were exported from Step One software v2.3
and imported into Matlab-2018b program, where the
melting curves were first translated with a translation
function and afterward compared with the melting curve
database produced in reference strains in each hypervar-
iable region of 16srRNA gene (V1, V3, V6), individually.
A reference library based on Tm and melting curves of
19 reference strains was established for the identification
of pathogens. The Matlab program consists of three
main parts, reading data from exported raw data files
and preprocessing, analyzing data and assigning most
similar reference strains to each clinical isolate, and writ-
ing the answers to the file and visualizing.
In the beginning, the program was written with the
relevant codes and was executed by Matlab-2018b then
was classified as different clinical isolates and reference
strains. In the following, their melting curves and Tm
were compared to each other for organism’s identifica-
tion [39]. Herein, programming, processing, and analyz-
ing were performed by the designed program based on
hypervariable regions of the 16srRNA gene with
temperature range between 80.90 °C-89.90 °C (based on
obtained reference strains Tm). Detection criteria in
Matlab-2018b analysis are based on a comparison of ref-
erence strains to correspond Tm with the closest clinical
isolate Tm (for every three regions of the gene with dif-
ferent primers, individually). Indeed, Tm differentiation
distances between the reference strains and clinical iso-
lates were indicated with an aggregated difference index
(0 °C-1.4 °C) [43]. Tm peaks belong to 16srRNA V1, V3
and V6 regions in reference strains and clinical strains
were compared with each other in this program, and the
final results were taken according to the closet similarity
between these two groups.
In our study, sensitivity, specificity, PPV, NPV, and ac-
curacy were calculated for HRMA vs culture based on
the PCC definition of PJIs.
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